These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31725007)

  • 21. In search of an algorithm to prevent acute kidney injury.
    Dauerman HL
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1125-7. PubMed ID: 19926055
    [No Abstract]   [Full Text] [Related]  

  • 22. Lessons learned from the PRESERVE trial.
    Partovi S; Trischman T; Kang PS
    Br J Radiol; 2018 Jul; 91(1087):20180092. PubMed ID: 29770709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis.
    Su X; Xie X; Liu L; Lv J; Song F; Perkovic V; Zhang H
    Am J Kidney Dis; 2017 Jan; 69(1):69-77. PubMed ID: 27707552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current trials of interventions to prevent radiocontrast-induced nephropathy.
    Asif A; Garces G; Preston RA; Roth D
    Am J Ther; 2005; 12(2):127-32. PubMed ID: 15767830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to protect from contrast media-induced nephropathy?
    Scheller B
    Clin Res Cardiol; 2007 Mar; 96(3):125-9. PubMed ID: 17294353
    [No Abstract]   [Full Text] [Related]  

  • 26. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
    ACT Investigators
    Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
    Brophy DF
    Ann Pharmacother; 2002 Sep; 36(9):1466-70. PubMed ID: 12196069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-induced Nephropathy: Essentials and Concerns.
    Samadian F; Dalili N; Mahmoudieh L; Ziaei S
    Iran J Kidney Dis; 2018 May; 12(3):135-141. PubMed ID: 29891742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review.
    Busch SV; Jensen SE; Rosenberg J; Gögenur I
    J Interv Cardiol; 2013 Feb; 26(1):97-105. PubMed ID: 23240788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
    Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
    Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Intravenous and Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Low-Risk Patients: A Randomized Trial.
    Martin-Moreno PL; Varo N; Martínez-Ansó E; Martin-Calvo N; Sayón-Orea C; Bilbao JI; Garcia-Fernandez N
    Nephron; 2015; 131(1):51-8. PubMed ID: 26336919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
    Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
    G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiocontrast agents: wrongfully accused?].
    Diebold M; Kistler AD
    Ther Umsch; 2018; 75(6):359-364. PubMed ID: 30880616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are we still wondering or wandering in the dark?
    Cattano D
    Intern Emerg Med; 2011 Dec; 6(6):485-6. PubMed ID: 21416287
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute Kidney Injury, AKI - Update 2018].
    Patschan D; Müller GA
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1094-1096. PubMed ID: 30060280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy.
    Isenbarger DW; Kent SM; O'Malley PG
    Am J Cardiol; 2003 Dec; 92(12):1454-8. PubMed ID: 14675586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection from contrast-induced nephropathy: is the answer in?
    Dean LS
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):342-3. PubMed ID: 12594699
    [No Abstract]   [Full Text] [Related]  

  • 40. Contrast-medium-induced nephrotoxicity: are all answers in for acetylcysteine?
    Thomsen HS
    Eur Radiol; 2001; 11(12):2351-3. PubMed ID: 11734930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.